#United States #Chicago #Healthcare Innovations #Indocyanine Green #ICG Market

The Indocyanine Green Market: An Overview

Recent reports suggest that the indocyanine green (ICG) market is poised for dramatic growth over the next several years. As of 2025, the market was valued at around USD 180 million, and it is projected to reach approximately USD 380 million by 2031. This indicates a robust compound annual growth rate (CAGR) of 13.26% during this period.

Key Drivers of Growth

The ICG market's growth can largely be attributed to its increasing applications in various medical fields, particularly in surgery and diagnostic imaging. The spotlight is on fluorescence imaging, which has gained popularity as healthcare providers transition towards minimally invasive procedures that promise better patient outcomes. This trend emphasizes the critical need for enhanced visualizations during surgical operations, which ICG provides through its unique fluorescence properties.

Understanding Indocyanine Green

Indocyanine green is a dye used in medical diagnostics, particularly for evaluating liver function and conducting retinal imaging. Its ability to fluoresce under near-infrared light makes it exceptionally useful for real-time imaging during surgeries. As hospitals adopt advanced surgical modalities, ICG's role in augmented reality and visualization during procedures has solidified its importance in modern medicine.

Market Segmentation

The indocyanine green market can be segmented by several factors:

• - Form Type: It is available in solid and liquid forms, with the solid form taking a significant market share reaching nearly 69%.
• - Procedure Type: Diagnostic procedures represent the largest segment in the market.
• - End Users: Specialty clinics are expected to show the fastest growth, with a CAGR of 14.17% from 2026 to 2031.
• - Applications: The ophthalmic angiography segment takes the lead in usage, driven by its effectiveness in diagnosing retinal conditions.
• - Geography: North America holds the majority market share at 37% in 2025, leading in the integration of ICG in various medical fields.

Advances in Surgical Procedures

The use of indocyanine green is transforming how surgeries are performed, particularly with the rise of robotic-assisted techniques. Facilities like Stryker's 1688 AIM 4K Platform have begun integrating ICG fluorescence imaging to offer real-time perfusion assessments in a variety of surgical cases. This technology not only promises improved accuracy during procedures but also enhances patient safety and recovery times.

ICG in Robotic Surgery

With advances in robotic surgeries, ICG-based imaging is becoming a critical differentiator for surgical platforms. Systems like Intuitive Surgical's da Vinci platform are utilizing Firefly fluorescence imaging to aid in real-time decision-making, enhancing the precision of procedures in urology, gynecology, and oncology.

Implications for the Future

The future of the ICG market appears promising. As the burden of diseases affecting the retina and other organs increases, so does the necessity for early and accurate diagnostic methods. ICG fluorescence imaging has proven to provide better visualization compared to traditional angiography methods, which is paving the way for more confirmed clinical decision-making.

Conclusion

In conclusion, the indocyanine green market is set for unprecedented growth, driven by the intersection of technology and healthcare. As the medical field continues to embrace innovative imaging techniques, ICG is positioned to play a vital role in enhancing surgical outcomes and diagnostics across a spectrum of conditions. This convergence of healthcare technology not only points to a favorable market outlook but also aligns with a broader mission to improve patient care and outcomes globally.